GSK says plaintiffs seek voluntary dismissal of first Zantac lawsuit


Reuters | Updated: 17-08-2022 00:08 IST | Created: 17-08-2022 00:08 IST
GSK says plaintiffs seek voluntary dismissal of first Zantac lawsuit

GlaxoSmithKline Plc said on Tuesday that plaintiffs in the first scheduled U.S. lawsuit around heartburn drug Zantac will file a notice to voluntarily dismiss the case.

GSK's shares were hit last week by investor concerns about the litigation around potential cancer-causing impurities that prompted the drug's withdrawal from markets in 2019 and 2020.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

  • READ MORE ON:
  • U.S.
Give Feedback